Although the relationship between TAGE-modified caspase-3 and necrosis-like cell death currently remains unknown, TAGE-modified caspase-3 may play an important role in the mechanisms underlying cell death in the pathogenesis of NASH [85]. Here, CASP3 is linked to metabolic dysfunction-associated steatohepatitis.